| Biodistribution and radiation dosimetry of a novel gallium-68 radiopharmaceutical for positron emission tomography of cell death in patients with solid malignancies. | Biodistribution and radiation dosimetry of [68Ga]gallium 2,2'-(7-(4-((1-carboxy-4-((1-((carboxymethyl)amino)-3-((2-((4-(dihydroxyarsaneyl)phenyl)amino)-2-oxoethyl)thio)-1-oxopropan-2-yl)amino)-4-oxobutyl)amino)-1-carboxylato-4-oxobutyl)-1,4,7-triazonane-1,4-diyl)diacetate (68Ga NODAGA GSAO) for positron emission tomography (PET) of cell death in patients with solid malignancies. | ACTRN12621000641897 |
